These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Potential use of endothelial progenitor cells for regeneration of the vasculature. Yamahara K; Itoh H Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and vasculogenesis for therapeutic neovascularization. Murohara T Nagoya J Med Sci; 2003 May; 66(1-2):1-7. PubMed ID: 12848416 [TBL] [Abstract][Full Text] [Related]
11. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968 [TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials. Ben-Shoshan J; George J Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S; Lyden D Nat Med; 2003 Jun; 9(6):702-12. PubMed ID: 12778169 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014 [TBL] [Abstract][Full Text] [Related]